Background: Radiographic contrast media (CM) induce renal vasoconstriction and may initiate induced nephropathy. Endothelin (ET), a vasoconstrictor, and nitric oxide (NO), a vasodilator, which are synthesized in the kidney by the vascular endothelium as well as by tubular epithelial and glomerular mesangial cells, are key modulators of renal circulation after CM administration. Intravascular CM, in addition, induces pronounced diuresis and natriuresis. The aim of the present study was to evaluate and compare changes in endogenous vasoactive mediators and contrast-induced natriuresis after CM administration. Methods: Diagnostic angiographic procedures were performed in 14 patients (9 males and 5 females) using the non-ionic CM Iopamidol. Before and immediately after angiography, venous blood and urine samples were obtained. The urinary excretion of ET-1 and nitrates/nitrites (NOx), and the fractional excretion of sodium (FENa) were measured and analyzed. Results: The urinary excretion of both ET-1 and NOx increased significantly (p < 0.05) after angiography, and urinary ET-1 and NOx excretion was correlated with an increase in FENa (p < 0.05). Conclusion: Exposure to CM in humans is associated with an increase in urinary ET and NOx. The excretion of sodium following CM administration is associated with an increase in urinary ET and NOx. ET and NO might be important in the renal change in humans after CM administration.

Keywords:
Contrast media, Endothelin, Nitric oxide, Sodium, Angiography
1.
Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: A prospective study. Am J Med 1983;74:243–248.
2.
Murphy SW, Barrett BJ, Parfrey PS: Contrast nephropathy. J Am Soc Nephrol 2000;11:177–182.
3.
Barrett BJ: Contrast nephrotoxicity. J Am Soc Nephrol 1994;5:125–137.
4.
Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Contrast media-associated nephrotoxicity. Semin Nephrol 1997;17:15–26.
5.
Solomon R: Contrast-medium-induced acute renal failure. Kidney Int 1998;53:230–242.
6.
Murakami R, Tajima H, Kumazaki T: Effect of iomeprol on renal function immediately after abdominal angiography. Acta Radiol 1996;37:962–965.
7.
Murakami R, Tajima H, Kumazaki T, Yamamoto K: Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate. Acta Radiol 1998;39:368–371.
8.
Garcia R, Lachance D, Thibault G: Positive inotropic action, natriuresis and atrial natriuretic factor release induced by endothelin in the conscious rat. J Hypertens 1990;8:725–731.
9.
Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M: Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 2000;105:925–933.
10.
Matsumura Y, Taira S, Kitano R, Hashimoto N, Kuro T: Selective antagonism of endothelin ETA or ETB receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats. Biol Pharm Bull 1999;22:858–862.
11.
Jackson RW, Treiber FA, Harshfield GA, Waller JL, Pollock JS, Pollock DM: Urinary excretion of vasoactive factors are correlated to sodium excretion. Am J Hypertens 2001;14:1003–1006.
12.
Adachi Y, Hashimoto K, Ono N, Yoshida M, Suzuki Kusaba M, Hisa H, Satoh S: Renal effects of a nitric oxide donor, NOC 7, in anesthetized rabbits. Eur J Pharmacol 1997;324:223–226.
13.
Al Waili NS: Increased urinary nitrite excretion in primary enuresis: Effects of indomethacin treatment on urinary and serum osmolality and electrolytes, urinary volumes and nitrite excretion. BJU Int 2002;90:294–301.
14.
Noonan WT, Banks RO: The role of nitric oxide in saline-induced natriuresis and diuresis in rats. Proc Soc Exp Biol Med 1999;221:376–381.
15.
Pollock DM: Renal endothelin in hypertension. Curr Opin Nephrol Hypertens 2000;9:157–164.
16.
Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993;44:1217–1223.
17.
Clark BA, Kim D, Epstein FH: Endothelin and atrial natriuretic peptide levels following radiocontrast exposure in humans. Am J Kidney Dis1997;30:82–86.
18.
Murakami R, Machida M, Tajima H, Hayashi H, Uchiyama N, Kumazaki T: Plasma endothelin, nitric oxide and atrial natriuretic peptide levels in humans after abdominal angiography. Acta Radiol 2002;43:340–343.
19.
Modesti PA, Cecioni I, Migliorini A, Naldoni A, Costoli A, Vanni S, Serneri GG: Increased renal endothelin formation is associated with sodium retention and increased free water clearance. Am J Physiol 1998;275:H1070–H1077.
20.
Rubanyi GM, Romero JC, Vanhoutte PM: Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986;250:H1145–H1149.
21.
Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest 1989;83:336–342.
22.
Zeidel ML, Brady HR, Kone BC, Gullans SR, Brenner BM: Endothelin, a peptide inhibitor of Na+,K+-ATPase in intact renal tubular epithelial cells. Am J Physiol 1989;257:C1101–C1107.
23.
Clavell AL, Stingo AJ, Margulies KB, Brandt RR, Burnett JC Jr: Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am J Physiol 1995;268:F455–F460.
24.
Simonson MS, Dunn MJ: Endothelin peptides and the kidney. Annu Rev Physiol 1993;55:249–265.
25.
Bachmann S, Mundel P: Nitric oxide in the kidney: Synthesis, localization, and function. Am J Kidney Dis 1994;24:112–129.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.